Immediate Impact

2 from Science/Nature 59 standout
Sub-graph 1 of 24

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma
2023 Standout
4 intermediate papers

Works of D. Perroni being referenced

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network
2009
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.
1996

Author Peers

Author Last Decade Papers Cites
D. Perroni 137 40 41 76 10 199
Luisina Bruno 140 31 20 23 13 291
Célia Dupain 86 43 15 52 13 195
Robert P. Whitehead 113 34 30 47 11 177
Daqian Gu 112 53 33 34 7 284
Jay A. Moore 106 44 46 33 14 152
Emanuela Chimienti 115 34 13 28 13 267
Lei Yu 77 61 29 56 10 246
Puneet Singh 123 50 29 76 13 254
Ángel Castaño 130 29 95 38 12 266
Maddalena Centanni 212 55 17 23 11 290

All Works

Loading papers...

Rankless by CCL
2026